Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 35,000 employees in 75 countries, and markets its products in more than 180 countries.
Característiques principals
The EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme aims to identify promising and innovative young researchers who are developing their research activities in Europe. Selected candidates will have the opportunity to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at this year’s EASD Annual Meeting. The chosen candidates will be invited by EASD to present a lecture (25 minute lecture + 5 minute discussion) and will receive a commemorative diploma.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@imim.es Ext.: 1576
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Convocatòria (URL)
http://www.europeandiabetesfoundation.org/index.php/ct-menu-item-5/14-sample-data-articles/147-rising-star-programme
Requisits
Applicants should have demonstrated their ability in the field of diabetes research and must be employed by a non-profit institution based in Europe or an associated country.
Candidates for the EFSD Rising Star Fellowships Programme must be paid-up members of EASD and have a PhD, MD or equivalent degree. Applicants must be under the age of 38 on 1 January in the year of the award. Preference will be given to individuals who have consistently pursued a well-defined and innovative research line, leading to publications in high impact peer reviewed journals.
Dotació
Travel expenses, hotel and registration costs for the recipients will be covered.
Furthermore the award includes an EFSD research fellowship in the amount of Euro 30,000 payable to the recipient’s institution. The objective of the research fellowship is to encourage innovative research in the field of diabetes.

Arxius

Arxiu